Study of Etanercept for the Prevention of Complications Resulting From Hematopoietic Stem Cell Transplantation (HSCT)

NCT00141739 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Graft-Versus-Host Disease

Interventions

DRUG: Etanercept

Sponsor

University of Michigan Rogel Cancer Center